View in EDS

Dihydropyridine Calcium Channel Blocker Therapy and Risk of CKD Progression in Type 2 Diabetes Treated With Renin Angiotensin System Inhibitors and SGLT2 Inhibitors: A Real-World Retrospective Cohort Study.

Saved in:
Bibliographic Details
Title: Dihydropyridine Calcium Channel Blocker Therapy and Risk of CKD Progression in Type 2 Diabetes Treated With Renin Angiotensin System Inhibitors and SGLT2 Inhibitors: A Real-World Retrospective Cohort Study.
Authors: Agur T; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel., Steinmetz T; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel., Goldman S; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel., Zingerman B; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel., Bielopolski D; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel., Nesher E; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel.; Department of Transplantation, Rabin Medical Center, Petah Tikva, Israel., Fattal I; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel., Meisel E; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel., Rozen-Zvi B; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.; Gray Faculty of Medical and Health Sciences, Tel- Aviv University, Tel-Aviv, Israel.
Source: Kidney medicine [Kidney Med] 2026 May 08; Vol. 8 (7), pp. 101394. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101756300 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0595 (Electronic) Linking ISSN: 25900595 NLM ISO Abbreviation: Kidney Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2590-0595
DOI:10.1016/j.xkme.2026.101394